Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Total Non-Current Liabilities: 2017-2018

  • Astria Therapeutics' Total Non-Current Liabilities was N/A to $4.2 million in Q4 2018 from the same period last year, while for Dec 2018 it was $4.2 million, marking a year-over-year change of. This contributed to the annual value of $4.2 million for FY2018, which is N/A change from last year.
  • Latest data reveals that Astria Therapeutics reported Total Non-Current Liabilities of $4.2 million as of Q4 2018, which was down 53.45% from $9.0 million recorded in Q2 2017.
  • Over the past 5 years, Astria Therapeutics' Total Non-Current Liabilities peaked at $9.2 million during Q1 2017, and registered a low of $4.2 million during Q4 2018.
  • Over the past 2 years, Astria Therapeutics' median Total Non-Current Liabilities value was $9.0 million (recorded in 2017), while the average stood at $7.4 million.